Abbott Laboratories
ABT: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|Ff | LOCK|SL^xV | LOCK|%>yw$& |
Abbott Earnings: Offer Strong Finish to 2024
Abbott posted fourth-quarter performance that featured organic top-line growth of 9% and adjusted earnings rising by 12%, as its disparate divisions all displayed strength.
